Sivaram S Emani,Ari D Kappel,Shivani D Rangwala,Paulina Piwowarczyk,Nikita Singh,Joon Hyeok Choi,Alfred P See,Darren B Orbach
{"title":"Are brain arteriovenous malformations congenital or developmental? Evidence from paediatric age data.","authors":"Sivaram S Emani,Ari D Kappel,Shivani D Rangwala,Paulina Piwowarczyk,Nikita Singh,Joon Hyeok Choi,Alfred P See,Darren B Orbach","doi":"10.1093/brain/awaf190","DOIUrl":null,"url":null,"abstract":"The natural history of pediatric brain arteriovenous malformations (AVMs) remains uncertain, particularly regarding their origin (congenital versus postnatal) and risk of rupture. This study analyzes age-related patterns in AVM presentation from a single quaternary referral center. A retrospective review of 275 pediatric AVM cases from 2009-2022, was conducted using radiological, surgical, and hospital records to identify age at first hemorrhage and associated AVM characteristics. Two mathematical models were developed: (i) a congenital model with a variable age-dependent rupture risk, and (ii) a postnatal model of AVM development, assuming age-dependent variable incidence and a constant rupture rate. Data were normalized to institutional age-based presentation rates. Hemorrhagic presentation peaked between ages 7 and 14, before declining sharply, a trend which remained after normalization. A congenital model with age-dependent rupture rate accounted well for the empirical distribution, while the postnatal model overpredicted adolescent hemorrhage and could not account for the observed decline. However, the rising distribution of asymptomatic AVMs with age suggests that a purely congenital model is implausible. The study supports a model where pediatric brain AVMs are largely postnatally acquired, though likely very early, with age-dependent varying annual risk of rupture peaking at age 13, before declining to an adult risk rate.","PeriodicalId":9063,"journal":{"name":"Brain","volume":"37 1","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awaf190","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The natural history of pediatric brain arteriovenous malformations (AVMs) remains uncertain, particularly regarding their origin (congenital versus postnatal) and risk of rupture. This study analyzes age-related patterns in AVM presentation from a single quaternary referral center. A retrospective review of 275 pediatric AVM cases from 2009-2022, was conducted using radiological, surgical, and hospital records to identify age at first hemorrhage and associated AVM characteristics. Two mathematical models were developed: (i) a congenital model with a variable age-dependent rupture risk, and (ii) a postnatal model of AVM development, assuming age-dependent variable incidence and a constant rupture rate. Data were normalized to institutional age-based presentation rates. Hemorrhagic presentation peaked between ages 7 and 14, before declining sharply, a trend which remained after normalization. A congenital model with age-dependent rupture rate accounted well for the empirical distribution, while the postnatal model overpredicted adolescent hemorrhage and could not account for the observed decline. However, the rising distribution of asymptomatic AVMs with age suggests that a purely congenital model is implausible. The study supports a model where pediatric brain AVMs are largely postnatally acquired, though likely very early, with age-dependent varying annual risk of rupture peaking at age 13, before declining to an adult risk rate.
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.